If the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...

Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

Medicines are vital but useless if lost or spoiled. Pharmaceutical logistics ensures their safe delivery. DHL's Florstadt campus near Frank...

In March, the company announced a plan to ⁠invest ⁠more than $55 billion through early 2029 to build manufacturing facilities and research ...

Union Budget 2026: Union Finance Minister Nirmala Sitharaman highlighted customs duty exemptions for life-saving medicines in the Union Bud...

Indian Pharma must look at strengthening its presence in established markets in Latin America, China, Russia, Africa and East Europe. This ...

U.S. drugmakers are increasingly licensing drug candidates from Chinese biotech firms, with 14 such deals worth up to $18.3 billion signed ...

Donald Trump plans tariffs on pharmaceutical imports, which has led healthcare experts to worry about drug shortages. Common drugs like pai...

U.S. pharmaceutical imports surged in March, exceeding $50 billion, as drugmakers stockpiled inventory in anticipation of potential tariffs...

On April 8, President Trump announced that his administration would soon implement a “major tariff on pharmaceuticals” imported into the U....

Johnson & Johnson's first-quarter revenue and profit exceeded Wall Street expectations, driven by strong cancer drug sales. The company rai...

Fearing potential tariffs from President Trump's announcement, some European drugmakers are increasing air shipments of medications to the ...

U.S. hospitals and generic drugmakers are urging President Trump to exempt medical goods from new tariffs on Chinese imports, warning of po...

India has been demanding opening of China's IT and pharmaceutical sectors as part of measures to reduce over USD 51 billion trade deficit i...

On May 4, China said it had removed import duties on as many as 28 medicines, but the need for lengthy trials and approvals has dampened en...

China has exempted import tariffs (duties) for 28 drugs, including all cancer drugs, from May 1st. Good news for India's pharmaceutical ind...